A Day for Celebrating Cancer Survival
Pat yourself on the back… it’s National Cancer Survivors Day on Sunday, June 2. Cancer Survivors Day demonstrates that life after a cancer diagnosis can be a reality. It was first … Continue reading
Canadian Partnership Against Cancer Call for Applications: Advisory Groups
On behalf of the Canadian Cancer Action Network (CCAN), we would like to take this opportunity to make you aware of the Canadian Partnership Against Cancer Call for Applications: Advisory … Continue reading
B.C. Policy on Ovarian Cancer Prevention Gets International Support
A pioneering, B.C.-led surgical procedure aimed at preventing ovarian cancer has been deemed safe by a new Italian study published Thursday in the medical journal Gynecologic Oncology. B.C. experts have … Continue reading
Resources: Maintenance Therapy, Chronic Conditions, Hereditary Breast and Ovarian Cancers
Understanding Maintenance Therapy This section has been reviewed and approved by the Cancer.Net Editorial Board, 3/2013 Full article: http://www.cancer.net/all-about-cancer/cancernet-feature-articles/treatments-tests-and-procedures/explaining-maintenance-therapy?et_cid=31635509&et_rid=463565042&linkid=Read+more Maintenance therapy is the ongoing use of chemotherapy (the use of … Continue reading
Endometrial Cancer at Young Age Ups Risk for Colorectal Cancer
“Women diagnosed with endometrial cancer at age 50 or younger had a fourfold increased risk for a subsequent colorectal cancer diagnosis, according to a historical cohort study published recently in … Continue reading
Gene Wars: The Last-ditch Battle Over Who Owns the Rights to our DNA
“A US biotech company is fighting to protect the patents it took out on a test for a cancer-causing gene. Scientists say a win for the firm would set back … Continue reading
Finally a Way to Predict Bevacizumab Response?
David Kerr, Professor of Cancer Medicine at University of Oxford, United Kingdom, and past President of ESMO (European Society for Medical Oncology) discusses an article published in the Journal of … Continue reading
Enhanced Killing of Ovarian Carcinoma using Oncolytic Measles Vaccine Virus Armed with a Yeast Cytosine Deaminase and Uracil Phosphoribosyltransferase
“A promising approach to treat ovarian cancer is oncolytic virus therapy using measles vaccine virus (MeV). Arming of MeV with a prodrug-converting suicide-gene in combination with prodrug treatment highly enhanced … Continue reading
Differential Diagnosis and Clinical Relevance of Ovarian Carcinoma Subtypes
“Over the next 5 years, we will see a dramatic surge forward in our understanding of the molecular basis of the less-common subtypes of ovarian carcinoma (LGSC, EC, MC and … Continue reading
